Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · IEX Real-Time Price · USD

0.580

-0.048 (-7.66%)

At close: Apr 18, 2024, 4:00 PM

0.660

+0.080 (13.75%)

Pre-market: Apr 19, 2024, 5:38 AM EDT

Ensysce Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Selling, General & Admin	5.36	6.91	18.71	1.15	6.93	0	0.15
Research & Development	7.59	19.84	4.69	4.39	3.4	0	0
Other Operating Expenses	-2.23	-2.52	-3.53	-3.93	-1.76	0.96	0
Operating Expenses	10.72	24.22	19.87	1.61	8.57	0.96	0.15
Operating Income	-10.72	-24.22	-19.87	-1.61	-8.57	-0.96	-0.15
Interest Expense / Income	0.35	0.11	1.3	1	0.96	0	0
Other Expense / Income	-0.46	-0.16	7.92	-2.67	0.58	-3.64	-0.12
Pretax Income	-10.61	-24.17	-29.08	0.06	-10.1	2.68	-0.03
Income Tax	0	0	0	0	0	0.55	0
Net Income	-10.61	-24.17	-29.08	0.06	-10.1	2.12	-0.03
Preferred Dividends	0.01	0.91	0.8	0	0	0	0
Net Income Common	-10.63	-25.09	-29.89	0.06	-10.1	2.12	-0.03
Shares Outstanding (Basic)	2	0	0	0	0	0	0
Shares Outstanding (Diluted)	2	0	0	0	0	0	0
Shares Change	1158.34%	114.15%	22.15%	-33.68%	314.69%	-2.94%	-
EPS (Basic)	-4.69	-139.42	-355.72	-	-9.60	-52.80	-2.40
EPS (Diluted)	-4.69	-139.42	-355.72	-	-9.60	-52.80	-2.40
Free Cash Flow	-10.78	-17.88	-8.24	-1.25	-0.94	-1.24	-0.25
Free Cash Flow Per Share	-4.76	-99.39	-98.10	-18.98	-9.02	-49.51	-9.77
Effective Tax Rate	-	-	-	-	-	20.70%	-
EBITDA	-10.26	-24.06	-27.79	1.05	-9.14	2.68	-0.03
Depreciation & Amortization	0	0	0	0	0	0	0
EBIT	-10.26	-24.06	-27.79	1.05	-9.14	2.68	-0.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).